Adolescents In COVID-19 Vaccine Trials: As Pfizer Starts Dosing, US FDA Encouraging Other Sponsors

But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.

adolescent with mask vaccinated (source: iStock / Getty Images Plus)
FDA advisory committee discusses when COVID-19 vaccines should be tested in adolescents • Source: iStock/Getty Images Plus

Vaccine experts disagree on whether children should be included in COVID-19 vaccine clinical trials, as some contend more safety data must be gathered in adults before extending enrollment to the pediatric population.

The issue was raised during the first meeting of the US Food and Drug Administration’s Vaccines and Related Biologics Advisory...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet